Skip to content

The Allergy Diagnosis Protocol of ß Lactam Drugs

The Allergy Diagnosis Protocol of ß Lactam Drugs

Status
Active, not recruiting
Phases
Unknown
Study type
Observational
Source
ChiCTR
Registry ID
ChiCTR1900021051
Enrollment
Unknown
Registered
2019-01-26
Start date
2019-03-01
Completion date
Unknown
Last updated
2019-01-28

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

ß Lactam Drugs

Interventions

Case Series:N/A

Sponsors

Department of Otolaryngology, West China Hospital, Sichuan University
Lead Sponsor

Eligibility

Sex/Gender
All
Age
18 Years to 60 Years

Inclusion criteria

Inclusion criteria: 1. Inpatients with a complaint of drug allergy to ß lactam antibiotics in West China Hospital from August 2017 to August 2018; 2. Aged 18 to 60 years, male or female; 3. Patients must sign the informed consent.

Exclusion criteria

Exclusion criteria: 1. Severe heart disease; 2. Uncontrolled asthma (FEV1<70%); 3. Hypertension patients taking ß receptor blocker and/or ACEI; 4. Patients history indicates severe delayed allergic reaction. Allergy happens 1 hour later or even several days after having medicine, including Stevens-Johnson syndrome, toxic epithelial necrolysis, exfoliative dermatitis and DRESS syndrome; 5. Psychological disorder; 6. Patients experienced allergic shock after using penicillin or having a skin test of penicillin within 10 years.

Design outcomes

Primary

MeasureTime frame
serum specific IgE;skin prick test;intradermal test;oral challenge test;basophil activation test;

Countries

China

Contacts

Public ContactMeng Juan

Department of Otolaryngology, West China Hospital, Sichuan University

Mjmelinda@163.com+86 18980606505

Outcome results

None listed

Source: ChiCTR (via WHO ICTRP) · Data processed: Feb 4, 2026